Latest News

Transcatheter valve implantation: exceeding expectations
Written by: http://www.opsens.com/pdf/2015-05-20_Pljls_en_version_cnw.pdf
Opsens announces first use of its FFR products by Dr. Nico Pijls
SYNERGY™ Bioabsorbable Polymer Stent System performs well Over Four Years
Direct flow medical® reports excellent two year data for its transcatheter aortic heart valve system
Advances in mechanical thrombectomy warrant call to action in acute stroke
Positive results for world's Smallest Pacemaker
Remote monitoring detects AF
Written by: http://www.inspiremd.com/en/press-center/inspiremd-announces-clinical-presentat…
InspireMD announces clinical presentations on CGuard and MGuard Systems with MicroNetTM Technology at…
Written by: http://www.escardio.org/The-ESC/Press-Office/Press-releases/Last-5-years/One-in…
One in five people will develop heart failure
Written by: http://www.globenewswire.com/news-release/2015/05/07/733633/0/en/nContact-Suppo…
nContact supporting continuing medical education symposium on persistent atrial fibrillation treatments at…

External news

Written by: Cardiac Vascular News
Arineta Launches First SpotLight™ Duo in Northeast at Lehigh Valley Health Network
Written by: Cardiovascular Business
It’s not what you eat, but when: Intermittent fasting boosts heart health of high-risk patients
Written by: Cardiovascular Business
LAMPOON before TMVR improves symptoms without complications, long-term data confirm
Written by: Medscape
From Fact to Fiction: Medical Journalist-Turned-Author
Written by: Medscape
Infographic: How Paychecks Look for Millennial Doctors
Written by: Medscape
Medicare Will Speed Coverage of Some 'Breakthrough' Devices
Written by: Medscape
Comorbidities Associated With Psoriasis: 5 Things to Know
Written by: Cardiovascular Business
Rising heart failure, AFib rates a ‘wake-up call’ for US cardiologists
Written by: Cardiovascular Business
Do cancer treatments increase a patient's risk of cardiovascular disease?
Written by: Cardiovascular Business
New-look TAVR valve recently acquired by Edwards may reduce risk of coronary obstruction